sarepta.com (SRPT) - Earnings per share increase in current year

Official company branding of Sarepta Therapeutics, Inc. (SRPT)

Risks of trial failures and the high cost of therapy create volatility that, through patent monopoly, transforms into high margins. Fluctuations in annual EPS confirm this trend, with the figure recorded at 134.30. Its status as a leader in muscular dystrophy treatment ensures a steady cash flow for Sarepta Therapeutics, Inc. (SRPT) due to the uniqueness of its genetic products and the absence of market alternatives.

Sarepta Therapeutics (SRPT) - Earnings growth in current year from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company Sarepta (SRPT)

- market value and analyst target forecast:
Fundamental valuation:Sarepta Therapeutics, Inc.
Signature product of sarepta.com

This indicator measures the dynamics of net earnings per share, reflecting the growth or decline rates of capital efficiency compared to the same period last year. By analyzing the year-over-year percentage change in EPS, investors assess how large-scale investments in gene therapy and the development of Elevidys translate into real financial returns amid the peak R&D cycle of Sarepta Therapeutics, Inc. (SRPT).

Main competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|TWST: Earnings growth in current year|TXG - Expected net earnings per share growth this year|Earnings per share growth in current year Intellia|Earnings per share growth rate in current year Stoke Therapeutics STOK|Earnings growth in current year BLFS|Wave Life Sciences - Earnings per share growth this year|Earnings growth in current year MAZE (Maze Therapeutics, Inc.)|Earnings growth in current year Sionna Pharma SION|Prime Medicine Bio - Earnings growth in current year|Earnings per share increase in current year TSHA (Taysha)|QURE: Earnings growth in current year|MGTX - Expected net earnings per share growth this year|Net earnings per share growth this year RGNX|SLDB: Earnings per share increase in current year|Earnings per share growth in current year ocugen.com (OCGN)|Expected net earnings per share growth this year PacBio Corp|Earnings per share growth in current year Benitec Biopharma BNTC|DSGN: Earnings per share growth this year|RCKT - Earnings per share growth in current year|4dmoleculartherapeutics.com (FDMT) - Net earnings per share growth this year|lexeotx.com (LXEO) - Earnings per share growth in current year|Korro Bio, Inc (KRRO) - Earnings growth in current year|EDIT (editasmedicine.com) - Earnings growth in current year|Earnings per share growth this year SLN (silence-therapeutics.com)|Earnings per share growth in current year proqr.com (PRQR)|Codexis - Earnings per share growth this year|Earnings growth in current year SGMO (Sangamo Therapeutics)|Earnings growth in current year nautilus.bio NAUT|Metagenomi Inc. - Earnings growth in current year|DTIL (Precision BioSciences Inc.) - Earnings per share growth this year|GBIO: Earnings growth in current year|Earnings per share growth rate in current year Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Earnings growth in current year|Net earnings per share growth this year Imunon (IMNN)|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year